A DNA methylation markers panel for prediction of luminal B breast cancer neoadjuvant chemotherapy response by quantitative PCR

被引：0

作者：

Nikolaeva, A. ^{[1
]}

Sigin, V. ^{[1
]}

Kalinkin, A. I. ^{[1
]}

Litviakov, N. V. ^{[2
]}

Slonimskaya, E. ^{[2
]}

Tsyganov, M. ^{[2
]}

Kharitonova, A. ^{[3
]}

Vinogradov, I. ^{[4
]}

Vinogradov, M. ^{[5
]}

Strelnikov, V. V. ^{[1
]}

Tanas, A. S. ^{[1
]}

Vinogradov, I. ^{[4
]}

机构：

[1] Res Ctr Med Genet, Epigenet, Moscow, Russia

[2] Tomsk Natl Res Med Ctr, Canc Res Inst, Tomsk, Russia

[3] Minist Hlth Russian Federat, A Tsyb Med Radiol Res Ctr, Branch Natl Med Res Radiol Ctr, Obninsk, Russia

[4] Ryazan Reg Clin Oncol Dispensary, Pathol & Anat Dept, Pathol Lab, Ryazan, Russia

[5] Ryazan State Med Univ, Oncol, Ryazan, Russia

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

基金：

俄罗斯科学基金会;

关键词：

D O I：

10.1016/j.annonc.2021.08.350

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

70P

引用

页码：S386 / S386

页数：1

共 50 条

[31] Clinical imaging for the prediction of neoadjuvant chemotherapy response in breast cancer
Hayashi, Mitsuhiro
Yamamoto, Yutaka
Iwase, Hirotaka
CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
[32] Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer
Koichi Nagasaki
Yoshio Miki
Breast Cancer, 2008, 15 : 117 - 120
[33] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
I F Faneyte
J G Schrama
J L Peterse
P L Remijnse
S Rodenhuis
M J van de Vijver
British Journal of Cancer, 2003, 88 : 406 - 412
[34] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
Faneyte, IF
Schrama, JG
Peterse, JL
Remijnse, PL
Rodenhuis, S
van der Vijver, MJ
BRITISH JOURNAL OF CANCER, 2003, 88 (03) : 406 - 412
[35] Serum proteins as predictive markers of the response to neoadjuvant chemotherapy for breast cancer
Steenbuck, Ines Derya
Cosenza, Miguel
Froehlich, Klemens
Mayer, Bettina
Werner, Tilman
Jaeger, Markus
Weiss, Daniela
Noething, Claudia
Schilling, Oliver
Erbes, Thalia
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 14 - 14
[36] A seven-gene methylation markers panel: An epigenetic predictor of neoadjuvant chemotherapy sensitivity in triple-negative breast cancer
Sigin, V. O.
Kalinkin, A. I.
Ignatova, E.
Sycheva, A. V.
Vinogradov, I. I.
Vinogradov, M. I.
Vinogradov, I. Y.
Zaletaev, D. V.
Strelnikov, V. V.
Tanas, A. S.
ANNALS OF ONCOLOGY, 2019, 30
[37] Global DNA methylation and response prediction of neoadjuvant chemoradiotherapy in rectal cancer
Tsang, J. S.
Leen, E.
Kay, E. W.
Deasy, J.
McNamara, D. A.
Mulligan, E. D.
BRITISH JOURNAL OF SURGERY, 2010, 97 : S23 - S24
[38] Neoadjuvant Chemotherapy for Luminal a Breast Cancer: Factors Predictive of Histopathologic Response and Oncologic Outcome
Collins, P.
Brennan, M.
Elliott, J.
Elwahab, S. A.
Barry, K.
Sweeney, K.
Malone, C.
Lowery, A.
McLaughlin, R.
Kerin, M.
BRITISH JOURNAL OF SURGERY, 2020, 107 : 23 - 23
[39] Neoadjuvant Chemotherapy for Luminal A Breast Cancer: Factors Predictive of Histopathologic Response and Oncologic Outcome
Collins, P.
Brennan, M.
Elliott, J.
Abd Elwahab, S.
Barry, K.
Sweeney, K.
Malone, C.
Lowery, A.
McLaughlin, R.
Kerin, M. J.
IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S185 - S185
[40] Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
Thompson, Kevin J.
Leon-Ferre, Roberto A.
Sinnwell, Jason P.
Zahrieh, David M.
Suman, Vera J.
Metzger, Filho Otto
Asad, Sarah
Stover, Daniel G.
Carey, Lisa
Sikov, William M.
Ingle, James N.
Liu, Minetta C.
Carter, Jodi M.
Klee, Eric W.
Weinshilboum, Richard M.
Boughey, Judy C.
Wang, Liewei
Couch, Fergus J.
Goetz, Matthew P.
Kalari, Krishna R.
NAR CANCER, 2022, 4 (02):

← 1 2 3 4 5 →